Literature DB >> 12776214

Genetic strategies for antibacterial drug discovery.

Lynn Miesel1, Jonathan Greene, Todd A Black.   

Abstract

The availability of genome sequences is revolutionizing the field of microbiology. Genetic methods are being modified to facilitate rapid analysis at a genome-wide level and are blossoming for human pathogens that were previously considered intractable. This revolution coincided with a growing concern about the emergence of microbial drug resistance, compelling the pharmaceutical industry to search for new antimicrobial agents. The availability of the new technologies, combined with many genetic strategies, has changed the way that researchers approach antibacterial drug discovery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12776214     DOI: 10.1038/nrg1086

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  33 in total

1.  Structural and enzymatic analyses reveal the binding mode of a novel series of Francisella tularensis enoyl reductase (FabI) inhibitors.

Authors:  Shahila Mehboob; Kirk E Hevener; Kent Truong; Teuta Boci; Bernard D Santarsiero; Michael E Johnson
Journal:  J Med Chem       Date:  2012-06-08       Impact factor: 7.446

Review 2.  Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  Computational genome analyses of metabolic enzymes in Mycobacterium leprae for drug target identification.

Authors:  Anusuya Shanmugam; Jeyakumar Natarajan
Journal:  Bioinformation       Date:  2010-03-31

4.  Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials.

Authors:  Rebecca Steidl; Stacy Pearson; Robert E Stephenson; Nagender Ledala; Sutthirat Sitthisak; Brian J Wilkinson; Radheshyam K Jayaswal
Journal:  Antimicrob Agents Chemother       Date:  2008-06-09       Impact factor: 5.191

Review 5.  Two-dimensional gel electrophoresis in bacterial proteomics.

Authors:  Shirly O T Curreem; Rory M Watt; Susanna K P Lau; Patrick C Y Woo
Journal:  Protein Cell       Date:  2012-05-18       Impact factor: 14.870

Review 6.  Challenges of antibacterial discovery.

Authors:  Lynn L Silver
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

7.  High-frequency transposition for determining antibacterial mode of action.

Authors:  Hao Wang; David Claveau; John P Vaillancourt; Terry Roemer; Timothy C Meredith
Journal:  Nat Chem Biol       Date:  2011-09-04       Impact factor: 15.040

8.  Virtual screening of specific chemical compounds by exploring E.coli NAD+-dependent DNA ligase as a target for antibacterial drug discovery.

Authors:  Bashir Akhlaq Akhoon; Shishir K Gupta; Gagan Dhaliwal; Mugdha Srivastava; Shailendra K Gupta
Journal:  J Mol Model       Date:  2010-05-05       Impact factor: 1.810

9.  Experimental Evolution of Diverse Strains as a Method for the Determination of Biochemical Mechanisms of Action for Novel Pyrrolizidinone Antibiotics.

Authors:  Kathryn Beabout; Megan D McCurry; Heer Mehta; Akshay A Shah; Kiran Kumar Pulukuri; Stephan Rigol; Yanping Wang; K C Nicolaou; Yousif Shamoo
Journal:  ACS Infect Dis       Date:  2017-09-27       Impact factor: 5.084

10.  Genome subtraction for novel target definition in Salmonella typhi.

Authors:  Bhawna Rathi; Aditya N Sarangi; Nidhi Trivedi
Journal:  Bioinformation       Date:  2009-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.